Albireo Pharma (NASDAQ:ALBO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Albireo Pharma missed estimated earnings by 18.38%, reporting an EPS of $-2.19 versus an estimate of $-1.85.
Revenue was up $4.87 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.78 which was followed by a 2.72% drop in the share price the next day.
Here’s a look at Albireo Pharma’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.35 | -0.38 | -1.96 | -1.77 |
| EPS Actual | -0.57 | -2.03 | -1.90 | -2.29 |
| Revenue Estimate | 12.48M | 3.48M | 1.98M | 2.13M |
| Revenue Actual | 32.52M | 3.66M | 2.43M | 1.97M |
To track all earnings releases for Albireo Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
